Shilpa Pharma Lifesciences’ Raichur API facility clears second consecutive FDA inspection with no… EP News Bureau Apr 9, 2025 Shilpa Medicare's Unit-2 API facility in Raichur, India passes March 2025 FDA audit without Form 483 observations, reinforcing…
